Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2009The Journal of Urology

Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration

View Full Paper
Ask AI
Bookmark
Share

Authors

NHNicholas J. HellenthalBassett Medical CenterSSShahrokh F. ShariatSemmelweis UniversityVMVitaly MargulisThe University of Texas Southwestern Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hellenthal et al. (2009) studied this question.

synapsesocial.com/papers/6a6f2afbe71d69abee07e2b9https://doi.org/10.1016/j.juro.2009.05.011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor grade and stage as prognostic variables in upper tract urothelial tumors1988 · 242 citations
  2. 2M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium1988 · 629 citations
  3. 3Adjuvant Chemotherapy in the Management of pT3N0M0 Transitional Cell Carcinoma of the Upper Urinary Tract2006 · 58 citations
  4. 4Tumors of the Upper Urinary Tract: 10 Years of Experience1991 · 171 citations
  5. 5Randomized Phase II Trial of Paclitaxel Plus Carboplatin or Gemcitabine Plus Cisplatin in Eastern Cooperative Oncology Group Performance Status 2 Non–Small-Cell Lung Cancer Patients: ECOG 15992007 · 87 citations